EUVIMEDEUVIMED entdecken
Crossref

All-trans retinoic acid-driven immune remodeling in esophageal squamous cell carcinoma revealed by single-cell transcriptomics

Tianshuo Yang, Ying Huang, Yaxin Liu, Yuqing Wang, Xinyu Zhu, Haoyu Shi, Suli Dai, Lianmei Zhao, Lei Li

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2027

DOI: 10.1016/j.bbadis.2026.168491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2027. Verfasst von Tianshuo Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research center, The Key Laboratory of Tumor Prevention and Precise Diagnosis & Treatment in Hebei Province, the Fourth Hospital of Hebei Medical Uni…. Hauptthemen laut MEDLINE: Tretinoin, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Transcriptome. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Hebei Provincial Natural Science Foundation, Hebei Province Medical Science Research Key Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) remains a highly lethal malignancy with limited durable responses to current therapies. Our previous work showed that all-trans retinoic acid (ATRA) upregulates the deubiquitinase OTUD6B and suppresses ESCC stemness. Here, we integrated in vivo pharmacological treatment, single-cell RNA sequencing, bulk RNA sequencing, immunofluorescence, flow cytometry, and OTUD6B disruption to define how ATRA remodels ESCC tumors. In a syngeneic mEC25 tumor model, ATRA inhibited tumor growth, and the ATRA-plus-anti-PD-1 group showed greater tumor inhibition than the ATRA-alone group. Single-cell profiling of ATRA- and vehicle-treated tumors identified epithelial, stromal, lymphoid, and myeloid compartments and revealed extensive immune remodeling after ATRA treatment. ATRA reduced FOXP3-associated regulatory T-cell features, attenuated M2-like macrophage polarization, and expanded a CD74-high neutrophil state. In epithelial tumor cells, ATRA-regulated genes were enriched in ubiquitination-related protein homeostasis, including protein ubiquitination, ubiquitin-dependent protein catabolism, and proteasome-mediated degradation. These findings prompted transcriptomic analysis of human ESCC cells treated with ATRA or subjected to OTUD6B silencing. ATRA treatment was negatively associated with hallmark epithelial-mesenchymal transition (EMT) enrichment, whereas OTUD6B knockdown was positively associated with EMT enrichment. Importantly, OTUD6B disruption attenuated ATRA-associated tumor suppression and abolished ATRA-induced reductions in CD25+FOXP3+ regulatory cells and F4/80+CD206+ macrophages, as well as the induction of CD74+ neutrophils. These data support a possible contribution of OTUD6B to ATRA responsiveness and provide a rationale for further evaluation of ATRA-based immunotherapy combinations in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TretinoinEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsTranscriptomeAnimalsHumansMiceCell Line, TumorGene Expression Regulation, NeoplasticSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisT-Lymphocytes, RegulatoryTumor MicroenvironmentForkhead Transcription Factors

Stichwörter der Autor:innen

Tumor immune microenvironmentepithelial–mesenchymal transitionmacrophagesneutrophilsregulatory T cells

Substanzen

TretinoinForkhead Transcription Factors

Autor:innen und Institutionen

  • Research center, The Key Laboratory of Tumor Prevention and Precise Diagnosis & Treatment in Hebei Province, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Research center, The Key Laboratory of Tumor Prevention and Precise Diagnosis & Treatment in Hebei Province, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China; Department of Laboratory Medicine…
  • Research center, The Key Laboratory of Tumor Prevention and Precise Diagnosis & Treatment in Hebei Province, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Electronic address: lilei@hebmu.e…

Förderung

  • Hebei Provincial Natural Science Foundation
  • Hebei Province Medical Science Research Key Project
  • National Natural Science Foundation of China

Zitieren

APA

Yang, T., Huang, Y., Liu, Y., Wang, Y., Zhu, X., Shi, H., Dai, S., Zhao, L., & Li, L. (2027). All-trans retinoic acid-driven immune remodeling in esophageal squamous cell carcinoma revealed by single-cell transcriptomics. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168491

Vancouver

Yang T, Huang Y, Liu Y, Wang Y, Zhu X, Shi H, et al. All-trans retinoic acid-driven immune remodeling in esophageal squamous cell carcinoma revealed by single-cell transcriptomics. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2027. doi:10.1016/j.bbadis.2026.168491

BibTeX
@article{Yang2027,
  author = {Yang, Tianshuo and Huang, Ying and Liu, Yaxin and Wang, Yuqing and Zhu, Xinyu and Shi, Haoyu and Dai, Suli and Zhao, Lianmei and Li, Lei},
  title = {All-trans retinoic acid-driven immune remodeling in esophageal squamous cell carcinoma revealed by single-cell transcriptomics},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2027},
  doi = {10.1016/j.bbadis.2026.168491}
}
Kostenlos starten →